Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus

GLIA

Volumn 21, Issue 2, 1997, Pages 228-243

  Miller, John D ^a   Cummings, Joel ^a   Maresh, Grace A ^a   Walker, Doug G ^b   Castillo, Gerardo M ^a   Ngo, Catherine ^a   Kimata, Koji ^c   Kinsella, Michael G ^a   Wight, Thomas N ^a   Snow, Alan D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid; Animal model; Glia; Glycosaminoglycans; Proteoglycans; RT PCR

Indexed keywords

AMYLOID BETA PROTEIN; HEPARAN SULFATE; PERLECAN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MACROPHAGE; MALE; METABOLISM; MICROGLIA; MICROINJECTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HIPPOCAMPUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICROGLIA; MICROINJECTIONS; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RNA;

EID: 9844232624     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199710)21:2<228::AID-GLIA6>3.0.CO;2-2     Document Type: Article

References (61)

1. Banati, R.B., Gehrmann, J., Czech, C., Monning, U., Jones, L.L., Konig, G., Beyreuther, K., and Kreutzberg, G.W. (1993) Early and rapid de novo synthesis of Alzheimer βA4-amyloid precursor protein (APP) in activated microglia. Glia, 9:199-210.
2. Bertolotto, A., Manzardo, E., Iudicello, M., Guglielmone, R., and Riccio, A. (1995) Keratan sulfate is a marker of differentiation of ramified microglia. Brain Res., 86:233-241.
3. Buee, L., Ding, W., Anderson, J.P., Narindrasorasak, S., Kisilevsky, R., Boyle, N.J., Robakis, N.K., Delacourte, A., Greenberg, B., and Fillit, H.M. (1993a) Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res., 627:199-204.
4. Buee, L., Ding, W., Delacourte, A., and Fillit, H. (1993b) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res., 601:154-163.
5. Castillo, G.M., Cummings, J.A., Ngo, C., Yang, W., and Snow, A.D. (1996) Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar Aβ amyloid persistence in brain. J. Biochem., 120:433-444.
6. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
7. Cohen, I.R., Murdoch, A.D., Naso, M.F., Marchetti, D., Berd, D., and Iozzo, R.V. (1994) Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res., 54:5771-5774.
8. Couchman, J.R., Kapoor, R., Sthanam, M., and Wu, R. (1996) Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J. Biol. Chem., 271:9595-9602.
9. Dodge, G.R., Boesler, E.W., and Jimenez, S.A. (1995) Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells. Lab. Invest., 73:649-657.
10. Edwards, I.J., Xu, H., Obunike, J.C., Goldberg, I.J., and Wagner, W.D. (1995) Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that binds lipoprotein lipase. Art. Thromb. Vasc. Biol., 15:400-409.
11. Giulian, D. and Baker, T.J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci., 6:2163-2178.
12. Grässel, S., Cohen, I.R., Murdoch, A.D., Eichstetter, I., and Iozzo, R.V. (1995) The proteoglycan perlecan is expressed in the erythleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester. Mol. Cell Biochem., 145:61-68.
13. Guelstein, V.I., Tchypysheva, T.A., Ermilova, V.D., and Ljubimov, A.V. (1993) Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int. J. Cancer, 53:269-277.
14. Gumpta-Bansal, R., Frederickson, C.A., and Brunden, K.R. (1995) Proteoglycan-mediated inhibition of Aβ proteolysis. J. Biol. Chem., 270:18666-18671.
15. Hassell, J.R., Leyshon, W.C., Ledbetter, S.R., Tyree, B., Suzuki, S., Kato, M., Kimata, K., and Kleinman, H.K. (1985) Isolation of two forms of basement membrane proteoglycans. J. Biol. Chem., 260: 8098-8105.
16. Hefti, F., Hartikka, J., and Snachez-Ramos, J. (1989) Dissociated cholinergic neurons of the basal forebrain in culture. In: A Dissection and Tissue Culture Manual of the Nervous System. Alan R. Liss, New York, pp. 172-182.
17. Hsu, S.M., Raine, L., and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29:577-580.
18. Husby, G., Araki, S., Benditt, E.P., Benson, M.D., Cohen, A.S., Frangione, B., Glenner, G.G., Natvig, J.B., and Westermark, P. (1993) Nomenclature of amyloid and amyloidosis. Bull. WHO, 71:105-108.
19. Kallunki, P. and Tryggvason, K. (1992) Human basement membrane heparan sulfate proteoglycan core protein: A 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Cell. Biol., 116:559-571.
20. Kato, M., Koike, Y., Ito, Y., Suzuki, S., and Kimata, K. (1988a) Multiple forms of heparan sulfate proteoglycans in the Engelbreth-Holm-Swarm mouse tumor. J. Biol. Chem., 262:7180-7188.
21. Kato, M., Koike, Y., Suzuki, S., and Kimata, K. (1988b) Basement membrane proteoglycan in various tissues: Characterization using monoclonal antibodies to Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan. J. Cell Biol., 106:2203-2210.
22. Kim, S.U., Sato, Y., Silberberg, D.H., Pleasure, D.E., and Rorke, L.B. (1983) Long-term culture of human oligodendrocytes. Isolation, growth, and identification. J. Neurol. Sci., 62:295-301.
23. Kinsella, M.G. and Wight, T.N. (1988) Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures. Biochem., 27:2136-2144.
24. Kitamoto, T., Ogomori, K., Tateishi, J., and Prusiner, S.B. (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest., 57:230-236.
25. Kovalsky, I., Schaff, Z., and Jeney, A. (1993) Potential markers (enzymes, proteoglycans) for human liver tumors. Acta Biomed. Ateneo Parmense, 64:157-163.
26. Maresh, G.A., Erezyilmaz, D., Murry, C.E., Nochlin, D., and Snow, A.D. (1996) Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J. Neurochem., 67:1132-1144.
27. Mattiace, L.A., Davies, P., Yen, S.H., and Dickson, D.W. (1990) Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropath., 80:493-498.
28. McCarthy, K.D. and De Vellis, J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol., 85:890-902.
29. McGeer, P.L., Akiyama, H., Itagaki, S., and McGeer, E.G. (1989a) Activation of the classical complement pathway in the brain tissue of Alzheimer patients. Neurosci. Lett., 107:341-346.
30. McGeer, P.L., Akiyama, H., Itagaki, S., and McGeer, E.G. (1989b) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci., 16:516-527.
31. Murdoch, A., Dodge, G., Cohen, I., Tuan, R., and Iozzo, R. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem., 267:8544-8557.
32. Murdoch, A.D., Liu, B., Schwarting, R., Tuan, R.S., and Iozzo, R.V. (1994) Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem., 42:239-249.
33. Narindrasorasak, S., Lowry, D.E., Gonzalez-DeWhitt, P.A., Poorman, R.A., Greenberg, B.D., and Kisilevsky, R. (1991) High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteolgycan. J. Biol. Chem., 266:12878-12883.
34. Nikkari, S.T., Jarvelainen, H.T., Wight, T.N., Ferguson, M., and Clowes, A.W. (1994) Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am. J. Pathol., 144:1348-1356.
35. Noonan, D.M., Fulle, A., Valente, P., Cai, S., Horigan, E., Sasaki, M., Yamada, Y., and Hassell, J.R. (1991) The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem., 266:22939-22947.
36. Owens, R.T. and Wagner, W.D. (1991) Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages. Arterioscler. Thromb., 11:1752-1758.
37. Perlmutter, L.S. and Chui, H.C. (1990) Microangiopathy, the vascular basement membrane, and Alzheimer's disease: A review. Brain Res. Bull., 24:677-686.
38. Perlmutter, L.S., Chui, H.C., Saperia, D., and Athanikar, J. (1990) Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res., 508:13-19.
39. Puchtler, H., Sweat, F., and Levine, M. (1962) On the binding of congo red by amyloid. J. Histochem. Cytochem., 10:355-364.
40. Rescan, P.Y., Loreal, O., Hassell, J.R., Yamada, Y., Guillouzo, A., and Clement, B. (1993) Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am. J. Pathol., 142:199-208.
41. Saku, T. and Furthmayr, H. (1989) Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. J. Biol. Chem., 264:3514-3523.
42. Schonherr, E., Jarvelainen, H.T., Sandell, L.J., and Wight, T.N. (1991) Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a larger versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem., 266:17640-17647.
43. Sekiguchi, R.T., Potter-Perigo, S., Braun, K., Miller, J., Ngo, C., Fukuchi, K., Wight, T.N., Kimata, K., and Snow, A.D. (1994) Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. J. Neurosci. Res., 38:670-686.
44. Shigematsu, K., McGeer, P.L., Walker, D.G., Ishii, T., and McGeer, E.G. (1992) Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J. Neurosci. Res., 31:443-453.
45. Snow, A.D. and Wight, T.N. (1989) Proteoglycans in the pathogenesis of Alzheimer's disease. Neurobiol. Aging, 10:481-497.
46. Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy of Alzheimer's disease. Am. J. Pathol., 133:456-463.
47. Snow, A.D., Kinsella, M.G., Prather, P.B., Nochlin, D., Podlisny, M.B., Selkoe, D.J., Kisilevsky, R., Hassell, J.R., and Wight, T.N. (1989) A characteristic binding affinity between heparan sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease. J. Neuropath. Exp. Neurol., 48:352. Abstract.
48. Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y., and Wight, T.N. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol., 137:1253-1270.
49. Snow, A.D., Wight, T.N., Mar, H., Bramson, R., and Kisilevsky, R. (1991) A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J. Histochem. Cytochem., 40:105-113.
50. Snow, A.D., Sekiguchi, R., Nochlin, D., Kalaria, R.N., and Kimata, K. (1994a) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol., 144:337-347.
51. Snow, A.D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mitzutani, A., Arai, M., Schreier, W.A., and Morgan, D.G. (1994b) An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ amyloid in rat brain. Neuron, 12:219-234.
52. Snow, A.D., Kinsella, M.G., Parks, E., Sekiguchi, R.T., Miller, J.D., Kimata, K., and Wight, T.N. (1995a) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys., 320:84-95.
53. Snow, A.D., Cummings, J.A., Ngo, C.T., Yang, W., Nochlin, D., Rimvall, K., Sheardown, M.J., and Judge, M. (1995b) Further studies implicating the importance of perlecan (a specific heparan sulfate proteoglycan) in an animal model of fibrillar Aβ amyloid deposition in vivo: Comparison of Aβ (1-42) versus Aβ (1-40). Soc. Neurosci., Abst. 21, 1282. Abstract.
54. Su, J.H., Cummings, B.J., and Cotman, C.W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51:801-813.
55. Uhlin-Hansen, L., Wik, T., Kjellen, L., Berg, E., Firsdahl, F., and Kolset, S.O. (1993) Proteoglycan metabolism in normal and inflammatory human macrophages. Blood, 82:2880-2889.
56. Van Gool, D., David, G., Lammens, M., Bare, F., and Dom, R. (1993) Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia. Dementia, 4:308-314.
57. Walker, D.G. and McGeer, P.L. (1992) Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res., 14:109-116.
58. Walker, D.G., Kim, S.U., and McGeer, P.L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res., 40:478-493.
59. Wintle, R.F., Kisilevsky, R., Noonan, D., and Duncan, A.M.V. (1990) In situ hybridization to human chromosome 1 of a cDNA probe for the gene encoding the basement membrane heparan sulfate proteoglycan (HSPG). Cytogenet. Cell Genet., 54:60-61.
60. Wisniewski, H.M., Wegiel, J., Wang, K.C., Kujawa, M., and Lach, B. (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci., 16:535-542.
61. Wrenshall, L.E., Cerra, F.B., Singh, R.K., and Platt, J.L. (1995) Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J. Immunol., 154:871-880.